{
    "Trade/Device Name(s)": [
        "First Sign Drug of Abuse Cup Test",
        "First Sign Drug of Abuse Dip Card Test"
    ],
    "Submitter Information": "W.H.P.M., Inc.",
    "510(k) Number": "K151441",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052115"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJR",
        "LCM",
        "DJG"
    ],
    "Summary Letter Date": "May 22, 2015",
    "Summary Letter Received Date": "May 29, 2015",
    "Submission Date": "June 26, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3620",
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Methadone test system",
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Methadone",
        "Phencyclidine",
        "Oxycodone"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Competitive binding",
        "Antigen-antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Test",
        "Dip Card",
        "Cup",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for First Sign Drug of Abuse Cup Test and Dip Card Test for qualitative detection of methadone, phencyclidine, and oxycodone in human urine",
    "Indications for Use Summary": "Qualitative determination of Methadone, Phencyclidine, and Oxycodone in human urine at specified cutoff concentrations; for preliminary screening results only in OTC and prescription use.",
    "fda_folder": "Toxicology"
}